Compare Duke Energy Corp (DUK) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Duke Energy Corp vs Twist Bioscience Corp — how do they compare? Duke Energy Corp trades at $116.51 (market cap $91.10B), while Twist Bioscience Corp trades at $155.76 (market cap $10.08B). The key difference: Duke Energy Corp is far larger — about 9× Twist Bioscience Corp's market cap, and Duke Energy Corp pays a 3.71% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Duke Energy Corp for 74 Days and Twist Bioscience Corp for 27 Days on average.
| DUK | TWST | |
|---|---|---|
Market Cap | $91.10B | $10.08B |
Volume | 4,199,050 | 4,229,037 |
Sector | Utilities | Health |
52-Week High | $133.46 | $205.00 |
52-Week Low | $113.23 | $25.45 |
Typical Hold Time | 74 Days | 27 Days |
Enterprise Value | $183.61B | $10.01B |
Dividend Yield | 3.71% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Duke Energy (DUK) trades at $115.5, down 0.14% on the day, amid a bearish technical signal. The stock shows strong fundamentals with consistent earnings beats, revenue growth from $28.8B in 2022 to $32.2B in 2025, and a net income margin of 15.78%. Recent news highlights dividend stability and data center-driven growth opportunities, though rising Treasury yields pressure utility stocks.
DUK offers a balanced outlook with steady dividends and growth from data center demand, but faces risks from high debt levels and interest rate sensitivity. Analyst consensus is mixed with a $135.33 price target, suggesting 17% upside, supported by a 43.75% buy rating. Investors should weigh solid profitability against macroeconomic headwinds.
TWST trades at $155.65, down 6.78% today, reflecting a bearish technical signal and recent earnings misses. Revenue growth is strong, rising to $376.57M in 2025, but profitability remains elusive with a net income margin of -31.66%. The company's partnership with Lilly TuneLab for AI-driven drug discovery has generated positive news flow, yet cash flow remains negative, and the stock trades at elevated valuation multiples like P/S of 22.01.
The outlook is mixed: strong analyst buy-side consensus (73% Buy) and strategic AI partnerships offer growth potential, but persistent losses, high cash burn, and bearish technicals pose significant risks. Investors face a trade-off between long-term innovation prospects and near-term financial instability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Duke Energy Corp
Duke Energy is one of the largest U.S. utilities, with regulated utilities in the Carolinas, Indiana, Florida, Ohio, and Kentucky that deliver electricity to nearly 8 million customers. Its natural gas utilities serve more than 1.5 million customers. Duke operates in three major segments: electric utilities and infrastructure
Read more on DUK →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
